The Preventive and Curative Effects of Lactobacillus reuteri NK33 and Bifidobacterium adolescentis NK98 on Immobilization Stress-Induced Anxiety/Depression and Colitis in Mice
Open accessThe DOI matches its Crossref record; 49 of the 50 references it cites were found in a registry or an index.
Abstract
The gut dysbiosis by stressors such as immobilization deteriorates psychiatric disorders through microbiota-gut-brain axis activation. To understand whether probiotics could simultaneously alleviate anxiety/depression and colitis, we examined their effects on immobilization stress (IS)-induced anxiety/depression and colitis in mice. The probiotics Lactobacillus reuteri NK33 and Bifidobacterium adolescentis NK98 were isolated from healthy human feces. Mice with anxiety/depression and colitis were prepared by IS treatment. NK33 and NK98 potently suppressed NF-κB activation in lipopolysaccharide (LPS)-induced BV-2 cells. Treatment with NK33 and/or NK98, which were orally gavaged in mice before or after IS treatment, significantly suppressed the occurrence and development of anxiety/depression, infiltration of Iba1+ and LPS+/CD11b+ cells (activated microglia) into the hippocampus, and corticosterone, IL-6, and LPS levels in the blood. Furthermore, they induced hippocampal BDNF expression while NF-κB activation was suppressed. NK33 and/or NK98 treatments suppressed IS-induced colon shortening, myeloperoxidase activity, infiltration of CD11b+/CD11c+ cells, and IL-6 expression in the colon. Their treatments also suppressed the IS-induced fecal Proteobacteria population and excessive LPS production. They also induced BDNF expression in LPS-induced SH-SY5Y cells in vitro. In conclusion, NK33 and NK98 synergistically alleviated the occurrence and development of anxiety/depression and colitis through the regulation of gut immune responses and microbiota composition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2 Oral administration of Lactobacillus reuteri NK33 and/or Bifidobacterium adolescentis NK98 attenuated IS-induced anxiety/depression and hippocampal inflammation in mice. (A) Procedure. Effects on anxiety/depression-like behaviors in elevated plus maze (B: (a), OT; (b), OE), LDT (C: (a), TL; (b), NT), tail suspension (D), and forced swimming (E) tasks. (F) Effects on hippocampal BDNF expression, and CREB and NF-κB activation. Effects on the infiltration of LPS+/CD11b+ (G) and Iba1+ cells (H) into the hippocampus. Effects on blood corticosterone (CORT, I), IL-6 (J), and LPS levels (K). Mice were exposed to IS and test agents (C, vehicle [1% maltose]; NK33, 1 × 109 CFU/mouse/day of NK33; NK98, 1 × 109 CFU/mouse/day of NK33; Mix, 1 × 109 CFU/mouse/day of the (1:1) mixture of NK33 and NK98]; and PC, 1 mg/kg/day of buspirone) were gavaged (for vehicle, NK33, and NK98) or intraperitoneally injected (for buspirone) daily for 5 days. Normal control group (NC), not exposed to IS, was treated with 1% maltose instead of test agents. Hippocampal p65, p-p65, CREB, p-CREB, BDNF, and β-actin were analyzed by immunoblotting. Blood IL-6, corticosterone, and LPS were assayed by ELISA kits. Iba1+ and LPS+/CD11b+ cells were measured using a confocal microscope. Data values were indicated as mean ± SEM (n = 7). # p < 0.05 vs. NC group. * p < 0.05 vs. IS alone treated group.](https://figures.cochat.ai/paper-figures/f295618ef0d346b6ab344642211ff120/the-preventive-and-curative-effects-of-lactobacillus-reuteri-nk33-and-figure-2.jpg)
![Figure 3 Oral administration of Lactobacillus reuteri NK33 and/or Bifidobacterium adolescentis NK98 alleviated immobilization stress (IS)-induced colitis in mice. Effects on the colon length (A), macroscopic score (B), myeloperoxidase (MPO) activity (C), IL-6 (D), IL-1β (E), and COX-2 expression, and NF-κB activation (F). Effects on the infiltration of CD11b+/CD11c+ cells into the colon (G), fecal microbiota composition (H), and fecal LPS levels (I). First, mice were exposed to IS and test agents (C, vehicle [1% maltose]; NK33, 1 × 109 CFU/mouse/day of NK33; NK98, 1 × 109 CFU/mouse/day of NK33; Mix, 1 × 109 CFU/mouse/day of the (1:1) mixture of NK33 and NK98]; and PC, 1 mg/kg/day of buspirone) were gavaged (for vehicle, NK33, and NK98) or intraperitoneally injected (for buspirone) daily for 5 days. Normal control group (NC), not exposed to IS, was treated with 1% maltose instead of test agents. Colonic p65, p-p65, COX-2, and β-actin were analyzed by immunoblotting. CD11b+ and CD11c+ cell populations were assayed using a confocal microscope. Fecal bacteria were assayed by qPCR. Fecal LPS assayed by ELISA kit. Data values are indicated as mean ± SEM (n = 7). # p < 0.05 vs. NC group. * p < 0.05 vs. IS group.](https://figures.cochat.ai/paper-figures/3a3ce012da5a43928f619d4fe82acd97/the-preventive-and-curative-effects-of-lactobacillus-reuteri-nk33-and-figure-3.jpg)
![Figure 4 Pretreatment with Lactobacillus reuteri NK33 and/or Bifidobacterium adolescentis NK98 protected IS-induced anxiety and hippocampal inflammation in mice. (A) Procedure. Effects on anxiety-like behaviors in elevated plus maze (B: (a), OT; (b), OE), LDT (C: (a), TL; (b), NT), tail suspension (D), and forced swimming (E) tasks. (F) Effects on hippocampal BDNF expression and CREB and NF-κB activation. Effects on the infiltration of LPS+/CD11b+ (G) and Iba1+ cells (H) into the hippocampus. Effects on blood corticoterone (CORT, I), IL-6 (J), and LPS levels (K). Test agents (C, vehicle [1% maltose]; NK33, 1 × 109 CFU/mouse/day of NK33; NK98, 1 × 109 CFU/mouse/day of NK33; Mix, 1 × 109 CFU/mouse/day of the (1:1) mixture of NK33 and NK98]; and PC, 1 mg/kg/day of buspirone) were gavaged (for vehicle, NK33, and NK98) or intraperitoneally injected (for buspirone) daily for 5 days and IS then exposed to mice. Normal control group (NC), not exposed to IS, were treated with 1% maltose instead of test agents. Hippocampal p65, p-p65, CREB, p-CREB, BDNF, and β-actin were assayed by immunoblotting. Blood corticosterone, IL-6, and LPS were assayed by ELISA kits. Iba1+ and LPS+/CD11b+ cells were measured using a confocal microscope. Data values are indicated as mean ± SEM (n = 7). # p < 0.05 vs. NC group. * p < 0.05 vs. IS group.](https://figures.cochat.ai/paper-figures/3ea3e24b41f3415eb8670cfd52bb7f70/the-preventive-and-curative-effects-of-lactobacillus-reuteri-nk33-and-figure-4.jpg)
![Figure 5 Pretreatment with Lactobacillus reuteri NK33 and/or Bifidobacterium adolescentis NK98 protected IS-induced colitis in mice. Effects on colon length (A), macroscopic score (B), colonic myeloperoxidase (MPO) activity (C), IL-6 (D), IL-1β (E), and COX-2 expression and NF-κB activation (F). (G) Effects on the CD11b+/CD11c+ cell infiltration into the colon. Effects on fecal microbiota composition (H) and fecal LPS levels (I). Test agents (C, vehicle [1% maltose]; NK33, 1 × 109 CFU/mouse/day of NK33; NK98, 1 × 109 CFU/mouse/day of NK33; Mix, 1 × 109 CFU/mouse/day of the (1:1) mixture of NK33 and NK98]; and PC, 1 mg/kg/day of buspirone) were gavaged (for vehicle, NK33, and NK98) or intraperitoneally injected (for buspirone) daily for 5 days and IS then exposed to mice. Normal control group (NC), not exposed to IS, were treated with 1% maltose instead of test agents. Colonic p65, p-p65, COX-2, and β-actin were analyzed by immunoblotting. CD11b+ and CD11c+ cells were assayed using a confocal microscope. Fecal bacteria were assayed by qPCR. Fecal LPS were assayed by ELISA kit. Data values are indicated as mean ± SEM (n = 7). # p < 0.05 vs. NC group. * p < 0.05 vs. IS group.](https://figures.cochat.ai/paper-figures/c1e4fc9b795244b2a30511a68364aa22/the-preventive-and-curative-effects-of-lactobacillus-reuteri-nk33-and-figure-5.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“such a treatment decreased the Proteobacteria population and bacterial LPS production in murine gut.”
From The Role of Microbiota-Gut-Brain Axis in Neuropsychiatric and Neurological Disorders (2021) · cites this paper as [130]
In the citing paper
“Jang et al. [130] showed that oral administration of the probiotics Lactobacillus reuteri NK33 and/or Bifidobacterium adolescentis NK98 isolated from healthy human feces suppressed the immobilization stress-induced anxiety and depression in mice.”
From The Role of Microbiota-Gut-Brain Axis in Neuropsychiatric and Neurological Disorders (2021) · cites this paper as [130]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Changes of Intestinal Functions in Liver Cirrhosis
Fukui, H., & Wiest, R. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000444436 · Cited by 6,808
Host-Bacterial Mutualism in the Human Intestine
Bäckhed, F., Ley, R. E., Sonnenburg, J. L., Peterson, D. A., & Gordon, J. I. (2005) · Science · doi:10.1126/science.1104816 · Cited by 5,277
Metagenomic Analysis of the Human Distal Gut Microbiome
Gill, S. R., Pop, M., DeBoy, R. T., Eckburg, P. B., Turnbaugh, P. J., Samuel, B. S., Gordon, J. I., Relman, D. A., Fraser-Liggett, C. M., & Nelson, K. E. (2006) · Science · doi:10.1126/science.1124234 · Cited by 4,699
Sudo, N., Chida, Y., Aiba, Y., Sonoda, J., Oyama, N., Yu, X., Kubo, C., & Koga, Y. (2004) · The Journal of Physiology · doi:10.1113/jphysiol.2004.063388 · Cited by 2,735 · cited 2×
“However, the fecal transplantation of conventional mice into germ-free mice suppresses anxiety [19].”
BackgroundThe gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems.
(2015) · PubMed Central · Cited by 2,540
Gut–brain axis: How the microbiome influences anxiety and depression
Foster, J. A., & McVey Neufeld, K.-A. (2013) · Trends in Neurosciences · doi:10.1016/j.tins.2013.01.005 · Cited by 2,460 · cited 1×
“The gut microbiota is bidirectionally connected to the brain: Dysfunction of the HPA axis by stressors can cause gut microbiota dysbiosis and psychiatric disorders and probiotics can alleviate anxiety [47,48].”
BackgroundThe role of the gut microbiota in nutrition and health
Flint, H. J., Scott, K. P., Louis, P., & Duncan, S. H. (2012) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2012.156 · Cited by 2,182
Epidemiology of anxiety disorders in the 21st century
Bandelow, B., & Michaelis, S. (2015) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2015.17.3/bbandelow · Cited by 2,079 · cited 1×
“Anxiety disorder is the most common disorder characterized by somatic, emotional, cognitive, and behavioral components [1,2].”
BackgroundMechanisms of action of probiotics
Plaza-Diaz, J., Ruiz-Ojeda, F. J., Gil-Campos, M., & Gil, A. (2019) · Advances in Nutrition · doi:10.1093/advances/nmy063 · Cited by 1,423 · cited 1×
“Probiotics, including bifidobacteria and lactobacilli, exhibit a variety of pharmacological activities: They alleviate constipation, diarrhea, imbalanced immune system, and psychiatric disorders [22,23].”
BackgroundKim, K.-A., Gu, W., Lee, I.-A., Joh, E.-H., & Kim, D.-H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047713 · Cited by 1,176 · cited 1×
“The endotoxin concentrations of feces and blood were assayed, as previously reported [31].”
MethodSelf-citation
Cited by
The Role of Microbiota-Gut-Brain Axis in Neuropsychiatric and Neurological Disorders
Socała, K., Doboszewska, U., Szopa, A., Serefko, A., Włodarczyk, M., Zielińska, A., Poleszak, E., Fichna, J., & Wlaź, P. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105840 · Cited by 857
Rastogi, S., & Singh, A. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1042189 · Cited by 326
Recent Development of Probiotic Bifidobacteria for Treating Human Diseases
Chen, J., Chen, X., & Ho, C. L. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.770248 · Cited by 241
Gut microbiota–brain axis in depression: the role of neuroinflammation
Carlessi, A. S., Borba, L. A., Zugno, A. I., Quevedo, J., & Réus, G. Z. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.14631 · Cited by 243
Xiao, J., Katsumata, N., Bernier, F., Ohno, K., Yamauchi, Y., Odamaki, T., Yoshikawa, K., Ito, K., & Kaneko, T. (2020) · Journal of Alzheimer's Disease · doi:10.3233/jad-200488 · Cited by 203
“Changes in brain BDNF have been reported for probiotics such as Bifidobacterium in rodent experiments [29] and have a beneficial effect on genes and inflammation pathways involved in neurological disorders [30].”
BackgroundAntidepressive Mechanisms of Probiotics and Their Therapeutic Potential
Yong, S. J., Tong, T., Chew, J., & Lim, W. L. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01361 · Cited by 204
Ge, L., Liu, S., Li, S., Yang, J., Hu, G., Xu, C., & Song, W. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1016578 · Cited by 187
“The immobilization stress (IS) induced the increase of fecal Proteobacteria population and overproduction of LPS, led to gut immune responses, and accelerated the development of colitis (111).”
BackgroundLee, H. J., Hong, J. K., Kim, J.-K., Kim, D., Jang, S. W., Han, S.-W., & Yoon, I. (2021) · Nutrients · doi:10.3390/nu13082660 · Cited by 190
“The probiotic NVP-1704 is a mixture of Lactobacillus reuteri NK33 and Bifidobacterium adolescentis NK98 isolated from the healthy human gut microbiota [17], and several preclinical trials have showed that NVP-1704 can alleviate anxiety and depression in mice by modulating gut immune responses and gut microbiota compos…”
BackgroundResultSelf-citationLinking What We Eat to Our Mood: A Review of Diet, Dietary Antioxidants, and Depression
Huang, Q., Liu, H., Suzuki, K., Ma, S., & Liu, C. (2019) · Antioxidants · doi:10.3390/antiox8090376 · Cited by 144
“For example, ginseng extract G115 and some probiotics, bifidobacterium adolescentis NK98 and Lactobacillus reuteri NK33, have been shown to attenuate depressional behavior by increasing brain-derived neurotrophic factor (BDNF) contents [10,11].”
BackgroundShao, S., Jia, R., Zhao, L., Zhang, Y., Guan, Y., Wen, H., Liu, J., Zhao, Y., Feng, Y., Zhang, Z., et al. (2021) · Phytomedicine · doi:10.1016/j.phymed.2021.153606 · Cited by 144
Gut microbiota and neurological effects of glyphosate
Rueda‐Ruzafa, L., Cruz, F., Román, P., & Cardona, D. (2019) · NeuroToxicology · doi:10.1016/j.neuro.2019.08.006 · Cited by 135
Guo, Y., Xie, J.-P., Deng, K., Li, X., Yuan, Y., Xuan, Q., Xie, J., He, X.-M., Wang, Q., Li, J.-J., et al. (2019) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2019.00126 · Cited by 122
Yue, Y., Ye, K., Lü, J., Wang, X., Zhang, S., Liu, L., Yang, B., Nassar, K. S., Xu, X., Pang, X., et al. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110159 · Cited by 123
Johnson, D., Thurairajasingam, S., Letchumanan, V., Chan, K., & Lee, L. (2021) · Nutrients · doi:10.3390/nu13051728 · Cited by 138
“adolescentis have been associated with reduced plasma IL-6 concentration [37,40].”
BackgroundMatsuda, Y., Ozawa, N., Shinozaki, T., Wakabayashi, K.-I., Suzuki, K., Kawano, Y., Ohtsu, I., & Tatebayashi, Y. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-0855-1 · Cited by 121
“decrease anxiety as measured on the elevated plus maze [34], reduce the stress-induced increase of corticosterone levels [35], and reduce despair-like behavior in mice [36, 37].”
BackgroundProbiotics in Treatment of Viral Respiratory Infections and Neuroinflammatory Disorders
Shahbazi, R., Yasavoli‐Sharahi, H., Alsadi, N., Ismail, N., & Matar, C. (2020) · Molecules · doi:10.3390/molecules25214891 · Cited by 115
Hormetic Nutrition and Redox Regulation in Gut–Brain Axis Disorders
Scuto, M. C., Rampulla, F., Reali, G. M., Spanò, S. M., Salinaro, A. T., & Calabrese, V. (2024) · Antioxidants · doi:10.3390/antiox13040484 · Cited by 109
“…(CFU)/day significantly inhibited NF-κ B activation, IL-6 expression and LPS levels, and induced hippocampal BDNF expression and CREB phosphorylation, alleviating anxiety and depression symptoms by suppressing gut dysbiosis through the inhibition of Proteobacteria in cells and in rodents [233].”
BackgroundHan, S., & Kim, D. H. (2019) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.1907.07044 · Cited by 88
Self-citationFecal Microbiota Changes in Patients With Postpartum Depressive Disorder
Zhou, Y., Chen, C., Yu, H., & Yang, Z. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.567268 · Cited by 92
Yu, Z., Chen, J., Liu, Y., Meng, Q., Liu, H., Yao, Q., Song, W., Ren, X., & Chen, X. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1095555 · Cited by 102
Review of microbiota gut brain axis and innate immunity in inflammatory and infective diseases
Yuan, C., He, Y., Xie, K., Feng, L., Gao, S., & Cai, L. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1282431 · Cited by 95
“Bi fi dobacterium and Lactobacillus , while administering Lactobacillus and Bi fi dobacterium isolated from healthy feces could alleviate the symptoms of depression in mice (Jang et al., 2019).”
BackgroundYun, S.-W., Kim, J.-K., Lee, K., Oh, Y. J., Choi, H., Han, M. J., & Kim, D. (2020) · Nutrients · doi:10.3390/nu12113441 · Cited by 86
“BDNF, CREB, p-CREB, p65, p-p65, and β-action expression levels were determined in the supernatants of the tissue homogenates by immunoblotting, as reported previously [16].”
BackgroundMethodResultSelf-citationDandekar, M. P., Palepu, M. S. K., Satti, S., Jaiswal, Y., Singh, A. A., Dash, S. P., Gajula, S. N. R., & Sonti, R. (2022) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.2c00143 · Cited by 77
Matisz, C. E., & Gruber, A. J. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.12.020 · Cited by 74
Tian, T., Xu, B., Qin, Y., Fan, L., Chen, J., Zheng, P., Gong, X., Wang, H., Bai, M., Pu, J., et al. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.06.053 · Cited by 70
Bifidobacterium: a probiotic for the prevention and treatment of depression
Li, J., Wang, J., Wang, M., Zheng, L., Cen, Q., Wang, F., Li, Z., Pang, R., & Zhang, A. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1174800 · Cited by 90
Probiotics for the treatment of depression and its comorbidities: A systemic review
Gao, J., Zhao, N., Cheng, Y., Lei, W., Wang, Y., Liu, X., Zheng, N., Shao, L., Chen, X., Sun, Y., et al. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1167116 · Cited by 87
“adolescentis NK98 42 male C57BL/6 mice 6 groups (n=7) each (NC, C, PC, NK33, NK98, and Mix) NK33 (1 × 10(9) CFU) NK98 (1 × 10(9) CFU) Mix (1 × 10(9) CFU 1:1 mixture of NK33 and NK98) maltose buspirone 5d ↓LPS; ↓GC; ↓IL-6; ↑BDNF; ↓NF-kB activation; ↓Proteobacteria; ↓Suppress anxiety/depression; Activated microglia infi…”
Wang, B., Kong, Q., Cui, S., Li, X., Gu, Z., Zhao, J., Zhang, H., Chen, W., & Wang, G. (2021) · Nutrients · doi:10.3390/nu13031017 · Cited by 66
“adolescentis treatment can reduce intestinal permeability and improve the intestinal barrier to reduce LPS passage across the intestinal barrier and suppress the NF-κB pathway and IL-6 generation [14,34].”
BackgroundHan, S., Shin, Y.-J., Lee, D.-Y., Kim, K., Yang, S.-J., Kim, D. S., Choi, J.-W., Lee, S., & Kim, D. (2021) · BMC Microbiology · doi:10.1186/s12866-021-02192-4 · Cited by 74
“1% sodium dodecyl sulfate (SDS), 1% phosphatase inhibitor cocktail and 1% protease inhibitor cocktail and were centrifuged (10,000 g, 4 °C, and 10min) [17].”
BackgroundMethodInfluentialSelf-citationThe Influence of Intestinal Microbiota on BDNF Levels
Molska, M., Mruczyk, K., Cisek-Woźniak, A., Prokopowicz, W., Szydełko, P., Jakuszewska, Z., Marzec, K., & Trocholepsza, M. (2024) · Nutrients · doi:10.3390/nu16172891 · Cited by 69
“More-over, they induced BDNF expression in the hippocampus [144].”
BackgroundHan, S., Joo, M.-K., Kim, J.-K., Jeung, W., Kang, H., & Kim, D. (2020) · Nutrients · doi:10.3390/nu12040901 · Cited by 66
“Each mouse (of Is, IR10, IR25, IL50, IF10, IF25, and IF50) except those in the control (Con) group was exposed to IS (12 h/day) for 2 days, as previously reported [7].”
InfluentialSelf-citationOpioid system influences gut-brain axis: Dysbiosis and related alterations
Rueda‐Ruzafa, L., Cruz, F., Cardona, D., Hone, A. J., Molina‐Torres, G., Sánchez‐Labraca, N., & Román, P. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104928 · Cited by 69
Liu, Y., Fang, H., Liu, H., Cheng, H., Pan, L., Hu, M., & Li, X. (2021) · Journal of Functional Foods · doi:10.1016/j.jff.2021.104491 · Cited by 65
Yoo, J.-W., Shin, Y.-J., Ma, X., Son, Y.-H., Jang, H., Lee, C. K., & Kim, D. (2022) · Nutrients · doi:10.3390/nu14102080 · Cited by 64
“Lactobacillus reuteri NK33 and Bifidobacterium adolescentis NK98 mitigate stress-induced depression and colitis in mice by the attenuation of gut dysbiosis [16,20].”
BackgroundMethodSelf-citationPalepu, M. S. K., Gajula, S. N. R., Malleshwari, K., Sonti, R., & Dandekar, M. P. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00727 · Cited by 70
Drugs and Bugs: The Gut-Brain Axis and Substance Use Disorders
Simpson, S., Mclellan, R., Wellmeyer, E., Matalon, F., & George, O. (2021) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-021-10022-7 · Cited by 69
“Blocking intestinal barrier degradation stops the translocation of MAMPs such as LPS, is a common trigger of the immune system which has been linked to the development of anxiety and depression-like behaviors in mice, which can exacerbate drug-taking behavior Jang et al. (2019).”
Remodeling of microbiota gut-brain axis using psychobiotics in depression
Palepu, M. S. K., & Dandekar, M. P. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.175171 · Cited by 69
Huang, C., Hao, W., Wang, X., Zhou, R., & Lin, Q. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1211271 · Cited by 72
Gut microbiota in dementia with Lewy bodies
Nishiwaki, H., Ueyama, J., Kashihara, K., Ito, M., Hamaguchi, T., Maeda, T., Tsuboi, Y., Katsuno, M., Hirayama, M., & Ohno, K. (2022) · npj Parkinson s Disease · doi:10.1038/s41531-022-00428-2 · Cited by 70
Qi, Y., He, J., Zhang, Y., Ge, Q., Wang, Q., Chen, L., Xu, J., Wang, L., Chen, X., Jia, D., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-41827-0 · Cited by 69
Balasubramanian, R., Bazaz, M. R., Pasam, T., Sharief, N., Velip, L., Samanthula, G., & Dandekar, M. P. (2022) · NeuroMolecular Medicine · doi:10.1007/s12017-022-08732-z · Cited by 58
“The phylum level changes were detected by qPCR analysis using iTaq Universal SYBR Green Supermix as described earlier (Dandekar et al., 2022; Jang et al., 2019).”
MethodPetracco, G., Faimann, I., & Reichmann, F. (2025) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2025.108831 · Cited by 64
Ruiz‐González, C., Román, P., Rueda‐Ruzafa, L., Rodríguez-Arrastia, M. J., & Cardona, D. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110189 · Cited by 55
Huang, F., Liu, X., Xu, S., Hu, S., Wang, S., Shi, D., Wang, K., Wang, Z., Lin, Q., Li, S., et al. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2021.805465 · Cited by 63
Chen, C.-Y., Wang, Y., Lei, L., & Zhang, Y. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122815 · Cited by 60
Gut microbial metabolism in Alzheimer's disease and related dementias
Kang, J. W., Vemuganti, V., Kuehn, J. F., Ulland, T. K., Rey, F. E., & Bendlin, B. B. (2024) · Neurotherapeutics · doi:10.1016/j.neurot.2024.e00470 · Cited by 60
Yang, Q., Luo, L., Sun, T., Yang, L., Cheng, L., Wang, Y., Liu, Q., Liu, A., Liu, H., Zhao, M., et al. (2020) · Psychopharmacology · doi:10.1007/s00213-020-05604-x · Cited by 53
Buspirone alleviates anxiety, depression, and colitis; and modulates gut microbiota in mice
Kim, J.-K., Han, S., Joo, M.-K., & Kim, D. (2021) · Scientific Reports · doi:10.1038/s41598-021-85681-w · Cited by 52
Self-citationAmelio, I., Bertolo, R. G., Bove, P., Candi, E., Chiocchi, M., Cipriani, C., Daniele, N. D., Ganini, C., Juhl, H. H., Mauriello, A., et al. (2020) · Biology Direct · doi:10.1186/s13062-020-00274-3 · Cited by 45
Gut microbiome-mediated mechanisms in aging-related diseases: are probiotics ready for prime time?
Ren, J., Li, H., Zeng, G., Pang, B., Wang, Q., & Wei, J.-P. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1178596 · Cited by 54
Thomann, A., Mak, J. W. Y., Zhang, J., Wüstenberg, T., Ebert, M. P., Sung, J. J. �., Bernstein, C. N., Reindl, W., & Ng, S. C. (2020) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15787 · Cited by 48
Bifidobacterium adolescentis – a beneficial microbe
Leser, T. D., & Baker, A. (2017) · Beneficial Microbes · doi:10.1163/18762891-20230030 · Cited by 61
Lactobacillus-Based Probiotics Reduce the Adverse Effects of Stress in Rodents: A Meta-analysis
Mindus, C., Ellis, J. L., van Staaveren, N., & Harlander-Matauschek, A. (2021) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2021.642757 · Cited by 48
“Thus, the final total number of studies retained in the final meta-analysis was 14 (Liu et al., 2016, 2019; Li et al., 2018;Morshedi et al., 2018; Jang et al., 2019; Liao et al., 2019; Murray et al., 2019; Sun et al., 2019; Wei et al., 2019; Stenman et al., 2020).”
BackgroundResultHe, H., Zhao, Z., Xiao, C., Li, L., Liu, Y., Fu, J., Liao, H., Zhou, T., & Zhang, J. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106396 · Cited by 43
“Higher abundance of Lactobacillus and Bifidobacterium has been linked to lower NF-κB activation, infiltration of activated microglia into the hippocampus, and levels of corticosterone, IL-6 and lipopolysaccharide in the blood (Jang et al., 2019; Messaoudi et al., 2011).”
BackgroundWestfall, S., Iqbal, U., Sebastian, M., & Pasinetti, G. M. (2019) · Progress in Molecular Biology and Translational Science · doi:10.1016/bs.pmbts.2019.06.013 · Cited by 41
Li, N., Li, J., Zhang, Q., Gao, S., Quan, X., Liu, P., & Xu, C. (2020) · Environmental Pollution · doi:10.1016/j.envpol.2020.116387 · Cited by 43
Liu, Y., Li, Y., Yu, X., Yu, L., Tian, F., Zhao, J., Zhang, H., Zhai, Q., & Chen, W. (2020) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.2003.03041 · Cited by 45
“Probiotics are receiving attention as a potential treatment for IBD, and strains including Bacillus licheniformis [4], Bacteroides fragilis [5], Bifidobacterium longum [6], Lactococcus lactis [7], Lactobacillus plantarum [8], Lactobacillus reuteri [9] and many others have been shown to restore body weight, regulate th…”
BackgroundGut microbiota in mental health and depression: role of pre/pro/synbiotics in their modulation
Methiwala, H. N., Vaidya, B., Addanki, V. K., Bishnoi, M., Sharma, S. S., & Kondepudi, K. K. (2021) · Food & Function · doi:10.1039/d0fo02855j · Cited by 40
Critical Review of the Cross-Links Between Dietary Components, the Gut Microbiome, and Depression
Randeni, N., & Xu, B. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26020614 · Cited by 46
Social overcrowding impacts gut microbiota, promoting stress, inflammation, and dysglycemia
Delaroque, C., Chervy, M., Gewirtz, A. T., & Chassaing, B. (2021) · Gut Microbes · doi:10.1080/19490976.2021.2000275 · Cited by 44
Rahman, Z., Bhale, N. A., Dikundwar, A. G., & Dandekar, M. P. (2023) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-023-10109-y · Cited by 44
“Lactobacillus reuteri is a non-pathogenic bacterium [119–121], and the reduced abundance of this bacteria was reported in stress-induced psychiatric disorders and traumatic brain injury [122, 123].”
Pain and Opioid-Induced Gut Microbial Dysbiosis
Thomas, K. R., Watt, J., Wu, C. M. J., Akinrinoye, A., Amjad, S., Colvin, L., Cowe, R., Duncan, S. H., Russell, W. R., & Forget, P. (2022) · Biomedicines · doi:10.3390/biomedicines10081815 · Cited by 39
“BDNF is another neurotransmitter that is reduced in depression.”
BackgroundInfluentialDuan, C., Huang, L., Zhang, C., Zhang, L., Xia, X., Zhong, Z., Wang, B., Wang, Y., Hoi, M. P. M., Ding, W., et al. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174338 · Cited by 43
Tan, J., Li, X., Zhu, Y., Sullivan, M. A., Deng, B., Zhai, X., & Lu, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.828595 · Cited by 42
“…with Lactobacillus-reuteri could alleviate anxiety and depressive-like behavior in mice, and its antidepressive effects are possibly associated with improved gut microbiota and serotonin metabolism, as well as GABA-related mechanisms (Jang et al., 2019; Xie et al., 2020; Zhou et al., 2022).”
BackgroundHong, M., Zhang, R., Liu, Y., Wu, Z., & Weng, P. (2021) · Journal of Food Biochemistry · doi:10.1111/jfbc.13870 · Cited by 39
Shin, Y.-J., Lee, D.-Y., Kim, J. Y., Heo, K., Shim, J.-J., Lee, J.-L., & Kim, D. (2022) · Journal of Ginseng Research · doi:10.1016/j.jgr.2022.08.004 · Cited by 36
“However, FMT or some probiotics, which relieve stressors-induced gut dysbiosis, alleviate colitis, leading to the decrease in AD [28,29].”
BackgroundSelf-citationMa, X., Kim, J.-K., Shin, Y.-J., Son, Y.-H., Lee, D.-Y., Park, H.-S., & Kim, D. (2023) · Nutrients · doi:10.3390/nu15153381 · Cited by 36
“The contents of LPS in the blood and feces were assayed by using the diazo-coupled limulus amoebocyte lysate (LAL) assays, as previously reported [28].”
MethodSelf-citationLiu, X., Zhang, B., Zhang, Y., Li, W., Yin, J., Shi, A., Wang, J., & Wang, S. (2024) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.3c08305 · Cited by 37
Han, S., Kim, J.-K., Joo, M.-K., Lee, K., Han, S.-W., & Kim, D. H. (2020) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.2002.02058 · Cited by 38
“adolescentis NK98 (NK98), and their (1:1) mixture were also reported to alleviate IS-induced anxiety/depression in mice [10].”
BackgroundSelf-citationGuo, X., Rao, Y., Mao, R., Cui, L., & Fang, Y. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108336 · Cited by 38
Xie, X., Li, W., Xiong, Z., Xu, J., Liao, T., Sun, L., Xu, H., Zhang, M., Zhou, J., Xiong, W., et al. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.09.014 · Cited by 36
Mesenchymal Stem Cell-derived Exosomes: Novel Therapeutic Approach for Inflammatory Bowel Diseases
Tian, C., Yang, M., Xu, H., Zhu, M., Zhang, Y., Yao, J., Wang, L., Liang, Y., & Li, D. (2023) · Stem Cells International · doi:10.1155/2023/4245704 · Cited by 42
“Repair of the IEB.”
InfluentialGholami, A., Dabbaghmanesh, M. H., Ghasemi, Y., Koohpeyma, F., Talezadeh, P., & Montazeri‐Najafabady, N. (2022) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-022-03713-y · Cited by 38
Ma, X., Son, Y.-H., Yoo, J.-W., Joo, M.-K., & Kim, D. (2022) · Nutrients · doi:10.3390/nu14142975 · Cited by 36
“Lactobacillus reuteri NK33 and Bifidobacterium adolescentis NK98 mitigate depression with gut inflammation by modifying gut microbiota [21].”
BackgroundSelf-citationZhao, Z., Xiao, G., Xia, J., Guo, H., Yang, X., Jiang, Q., Wang, H., Hu, J., & Zhang, C. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.09.018 · Cited by 41
Intratumoral microbiota: new frontiers in tumor immunity
Zhang, Z., Liao, Y., & Tang, D. (2022) · Carcinogenesis · doi:10.1093/carcin/bgac063 · Cited by 32
Pei, J., Zhang, C., Zhang, Q., Yu, H., Yuan, H., Guo, Y., Shen, H., Liu, H., Wang, C., Meng, F., et al. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-03017-y · Cited by 33
Lee, H. L., Kim, J. M., Moon, J. H., Kim, M. J., Jeong, H. R., Go, M. J., Kim, H., Eo, H. J., Lee, U., & Heo, H. J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010090 · Cited by 33
“reuteri also improved cognitive disorders related to mental health in anxiety-like behavior in the elevated plus maze task and depressive-like behavior in the forced swimming test and tail suspension test in immobilization stress-induced colitis mice [57].”
BackgroundGut microbiota: Candidates for a novel strategy for ameliorating sleep disorders
Li, L., Liang, T., Jiang, T., Li, Y., Yang, L., Wu, L., Yang, J., Ding, Y., Wang, J., Chen, M., et al. (2023) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2023.2228409 · Cited by 33
Martirosyan, D. M., & Leem, C. (2019) · Bioactive Compounds in Health and Disease · doi:10.31989/bchd.v2i10.431 · Cited by 35
“[57] Depression Lactobacillus reuteri, Bifidobacterium adolescentis Significantly suppressed occurrence and development of anxiety/depression Decrease in frequency and development of anxiety/depression”
BackgroundMerchak, A. R., Wachamo, S., Brown, L. C., Thakur, A., Moreau, G. B., Brown, R. M., Rivet-Noor, C. R., Raghavan, T. P., & Gaultier, A. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.11.001 · Cited by 35
“…was found to be a psychobiotic which aids in stress resistance, reduces disordered behavior in mice, and alleviates both self-reported depression and anxiety in patients (Marin et al., 2017; Bravo et al., 2011; Jang et al., 2019; Rudzki et al., 2019; Slykerman et al., 2017; Xu et al., 2022).”
The microbiota–gut–brain axis: A novel nutritional therapeutic target for growth retardation
Qi, M., Tan, B., Wang, J., Liao, S., Deng, Y., Ji, P., Song, T., Zha, A., & Yin, Y. (2021) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.1879004 · Cited by 29
“(Jang, Lee, and Kim 2019) Eating-disorder, mouse, # $ (n¼ 14) Lactobacillus johnsonii Q1-7 (orally gavaged with 5 109 CFU six days a week) 9 wk "Food intake (twice than control group), and body mass (more than 20% of origin weight).”
BackgroundHashikawa‐Hobara, N., Otsuka, A., Okujima, C., & Hashikawa, N. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.918953 · Cited by 31
“In contrast, prior studies showed that Lactobacillus reuteri NK33 and helveticus NS8 significantly suppress corticosterone levels in mice subjected to immobilization or chronic restraint stress (Liang et al., 2015; Jang et al., 2019).”
ResultMidya, V., Lane, J. M., Gennings, C., Torres-Olascoaga, L. A., Gregory, J. K., Wright, R. O., Arora, M., Téllez‐Rojo, M. M., & Eggers, S. I. (2023) · Environmental Science & Technology · doi:10.1021/acs.est.3c04346 · Cited by 29
A multispecies probiotic accelerates fear extinction and inhibits relapse in mice: Role of microglia
Cui, X., Zhou, S., Xia, G., Chen, J., Jiang, L., Huang, J., & Tong, J. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108613 · Cited by 26
Chronic ethanol exposure induced anxiety‐like behaviour by altering gut microbiota and GABA system
Yao, H., Zhang, D., Yu, H., Shen, H., Lan, X., Liu, H., Chen, X., Wu, X., Zhang, G., & Wang, X. (2022) · Addiction Biology · doi:10.1111/adb.13203 · Cited by 27
The microbiota-gut-brain axis in pathogenesis of depression: A narrative review
Yao, H., Zhang, D., Yu, H., Shen, H., Liu, H., Meng, F., Wu, X., Zhang, G., & Wang, X. (2022) · Physiology & Behavior · doi:10.1016/j.physbeh.2022.114056 · Cited by 35
Probiotic effects on anxiety-like behavior in animal models
Lalonde, R., & Strazielle, C. (2022) · Reviews in the Neurosciences · doi:10.1515/revneuro-2021-0173 · Cited by 30
The microbiota-gut- hippocampus axis
Salami, M., & Soheili, M. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.1065995 · Cited by 34
Li, L., Zou, H.-W., Song, B.-L., Wang, Y., Jiang, Y. H., Li, Z.-L., Niu, Q., & Liu, Y.-J. (2022) · Neuroendocrinology · doi:10.1159/000528876 · Cited by 25
Butterflies in the gut: the interplay between intestinal microbiota and stress
Lai, T.-T., Liou, C.-W., Tsai, Y.-H., Lin, Y.-Y., & Wu, W. (2023) · Journal of Biomedical Science · doi:10.1186/s12929-023-00984-6 · Cited by 29
“L. reuteri NK33, L. johnsonii isolates , L. johnsonii BS15 , and L. mucosae NK41 suppressed corticosterone elevation induced by immobilization stress [49, 196–198].”
BackgroundThe gut–brain connection: microbes’ influence on mental health and psychological disorders
Ataei, P., Kalantari, H., Bodnar, T. S., & Turner, R. J. (2026) · Frontiers in Microbiomes · doi:10.3389/frmbi.2025.1701608 · Cited by 41
Precision Postbiotics and Mental Health: the Management of Post-COVID-19 Complications
Pandey, M., Bhati, A., Priya, K. G. G. L. S., Sharma, K. K., & Singhal, B. (2021) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-021-09875-4 · Cited by 25
Li, C., Su, Z., Chen, Z., Cao, J., Liu, X., & Xu, F. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1149185 · Cited by 28
“reuteri might have therapeutic value in treating obesity and depression comorbidity (Jones et al., 2012; Li S. et al., 2019; Jang et al., 2019).”
BackgroundResultLiu, Z., Cao, Q., Wang, W., Wang, B., Yang, Y., Xian, C. J., Li, T., & Zhai, Y. (2024) · Microorganisms · doi:10.3390/microorganisms13010045 · Cited by 34
Yao, H., Shen, H., Yu, H. Q., Wang, C., Ding, R., Lan, X., Tash, D., Wu, X., Wang, X., & Zhang, G. (2021) · Physiology & Behavior · doi:10.1016/j.physbeh.2021.113387 · Cited by 25
Hamamah, S., Hajnal, A. S., & Covașă, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147503 · Cited by 25
“The probiotic also prevented activated microglia from permeating into the hippocampus [72].”
BackgroundLai, C., Chen, C., She, S.-C., Chen, W., Kuo, T. B. J., Lin, H., & Yang, C. C. H. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.120165 · Cited by 22
Bock, H.-J., Lee, N., & Paik, H. (2022) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.2304.04045 · Cited by 20
Assessment of optimal combinations of therapeutic probiotics for depression, anxiety, and stress
Yang, Y., Yang, L., Wan, M., Pan, D., Sun, G., & Yang, C. (2024) · Psychological Medicine · doi:10.1017/s0033291724000679 · Cited by 23
“Jiang et al. (Jang, Lee, & Kim, 2019) reported that Bifidobacterium species reduce IL-6 and cortico-sterone levels in the blood of stressed mice by decreasing the number of Iba1 + and LPS + /CD11b + cells (activated microglia) in the hippocampus and inhibiting the activation of the HPA axis,…”
Metadata
- Authors
- Jang, H.-M., Lee, K.-E., & Kim, D.-H.
- Affiliations
- Kyung Hee University (KR)
- Corresponding author
- Kim, Dong-Hyun
- ORCID
- Kim, Dong-Hyun
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2019-04-11
- Volume
- 11
- Issue
- 4
- Pages
- 819
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC6521032
- OpenAlex
- W2939407924
- Cited by
- 208
- References
- 50
- Citations by year
- 2026: 17 · 2025: 27 · 2024: 31 · 2023: 37 · 2022: 33 · 2021: 35 · 2020: 19 · 2019: 8
- FWCI
- 18.33
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Research Foundation of Korea (2017R1A5A2014768)
- Topics
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Keywords
- probiotics, restraint stress, anxiety, depression, colitis, microbiota-gut-brain axis, gut dysbiosis, NF-κB activation, lipopolysaccharide, microglial activation, hippocampus, brain-derived neurotrophic factor, interleukin-6, corticosterone, Proteobacteria, gut immune response
- MeSH terms
- Bifidobacterium adolescentis, Animals, Anxiety, Cell Line, Colitis, Depression, Humans, Lipopolysaccharides, Male, Mice, Inbred C57BL, Neuroblastoma, Restraint, Physical, Stress, Psychological, Tumor Cells, Cultured, NF-kappa B, Microglia, Probiotics, Mice, Limosilactobacillus reuteri, Dysbiosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.